Patients living with both advanced renal disease and diabetes can often
struggle with optimizing glycaemic control.
This trial utilizes the Medtronic MiniMed 780G system in patients
with type 1 and type 2 diabetes with advanced renal disease including
those on haemo dialysis and peritoneal dialysis, contrasted against
their usual care procedures.
By applying an artificial pancreas to automate insulin delivery and continuous
glucose monitoring using the MiniMed 780G system, this study seeks to help
alleviate the mental, emotional and physical burdens attached to patients and
comparing their usual care.